- Photocure and Artera to partner on digital pathology AI test evaluation for Bladder Cancer
All News Releases · Jun 8, 2026
Artera and Photocure have launched a joint research initiative to evaluate AI-powered digital pathology tests for bladder cancer. This partnership expands Artera's clinical footprint by integrating its precision medicine technology with Photocure's bladder cancer registry.
- Photocure and Artera to partner on digital pathology AI test evaluation for Bladder Cancer
UroToday · Jun 8, 2026
Photocure and Artera have launched a joint research initiative to validate the ArteraAI Bladder Test using Photocure's blue light cystoscopy registry data. This partnership aims to enhance precision medicine in uro-oncology by leveraging multimodal AI to improve bladder cancer treatment decisions.
- Artera Achieves FedRAMP® Class D Certification for Artera Harmony Federal Edition
PR Newswire · Jun 4, 2026
- Artera Achieves FedRAMP® Class D Certification for Artera Harmony Federal Edition
Yahoo Finance · Jun 4, 2026
- Artera Gains FedRAMP Class D Certification for Federal Healthcare Offering
TipRanks · Jun 4, 2026
Artera's Harmony Federal Edition platform has achieved FedRAMP Class D Certification, a significant security milestone that allows the company to expand its patient communication services to federal healthcare agencies like the VA and DoD.
- Tempus and Artera Collaborate to Expand Access to New Prognostic Test for Prostate Cancer
ASCO AI in Oncology · Jun 4, 2026
Tempus AI and Artera have integrated the ArteraAI Prostate Test into the Tempus platform, providing clinicians with advanced digital pathology tools to personalize treatment for patients with metastatic hormone-sensitive prostate cancer.
- Artera Harmony Federal Edition Meets FedRAMP Security Requirements and Is Granted an Authority to Operate
Artera Newsroom · Jun 4, 2026
Artera announced that its 'Artera Harmony Federal Edition' platform has achieved FedRAMP Authority to Operate, enabling the company to expand its patient communication and engagement services within federal healthcare agencies.
- New on Demand Episodes 6/2/26 - HealthcareNOWradio.com
HealthcareNOWradio.com · Jun 2, 2026
Artera CEO and Co-Founder Guillaume de Zwirek discusses the evolution of technology, the stages of agentic AI utilization, and strategies for effective AI deployment in healthcare settings.
- Health IT Product News Report June 2026
HealthcareNOWradio.com · Jun 1, 2026
This industry report highlights Artera's unveiling of its new AI Services Model for specialty care and FQHCs, marking the company's expansion into bespoke, provider-partnered AI solutions.
- Artera Announces AI Services Model for Specialty Care, FQHCs and More
PR Newswire · May 7, 2026
- Artera Announces AI Services Model for Specialty Care, FQHCs and More
PR Newswire · May 7, 2026
Artera unveiled a new AI Services Model designed to provide bespoke, agentic AI solutions for specialty care providers, FQHCs, and health systems, aiming to close the gap between technology and clinical workflows.
- Artera, Atlantic Health deploy AI agents for colonoscopy patient outreach
MobiHealthNews · Apr 1, 2026
- Atlantic Health Reduces Colonoscopy Screening Gaps Using Artera's AI Agents
PR Newswire · Mar 30, 2026
- Artera Strengthens Executive Leadership Team with Appointment of New CTO and Promotion of People Team Leader
PR Newswire · Mar 26, 2026
- Q&A: Artera's new CTO on bringing Amazon expertise to AI health tech strategy
MobiHealthNews · Mar 26, 2026
- HIMSS 2026: Artera to Showcase Real-World Applications of AI for Patient Communications and Access
PR Newswire · Mar 6, 2026
- Artera Named #1 Best in KLAS for Patient Communications
PR Newswire · Feb 27, 2026
- Artera Recognized by Deloitte in 2025 Technology Fast 500 And Announces Several Executive Appointments
Memorial Care Innovation Fund · Feb 23, 2026
- Beauregard Health System Improves Patient Experience By Unifying Post-Appointment Medication Communication
Memorial Care Innovation Fund · Feb 23, 2026
- OpenAI, Anthropic Shake Up Digital-Health Sector With Their Own Contenders
WSJ · Feb 5, 2026